The tools we use in research should reflect the full spectrum of genetic diversity, but they often do not. This is a gap that an international team of scientists is exploring through the lens of induced pluripotent stem cell (iPSC) lines. iPSCs are a type...
Receiving a heart transplant is a life-changing journey, and you may be wondering about your treatment options. This is why The Heart Hub is excited to introduce A Hearts Journey: A Patient & Caregiver Guide to Heart Transplant. This brand-new, interactive...
On March 5, 2025, The Hospital for Sick Children (SickKids) received a significant breakthrough in pediatric research with an $11.7 million award from Genome Canada. As part of the Canadian Precision Health Initiative, a total of $81 million in...
After eight transformative years at the Ted Rogers Centre for Heart Research (TRCHR), Dr. Soror Sharifpoor is embarking on an exciting new chapter in her career. As the Director of Strategy & Translation at the Translational Biology and Engineering Program (TBEP)...
With a mission to support novel approaches to managing and preventing heart failure, the Ted Rogers Centre for Heart Research uses its Innovation Fund to propel emerging research with great potential. The 2024-25 Innovation Fund Seed Grants are currently open and you...
The Ted Rogers Centre for Heart Research is delighted to welcome Iris Cohn as the new Innovator in Genomic Translation - also recently promoted to Director of the Pharmacogenetics (PGx) Program at The Hospital for Sick Children. A trained pharmacist, Iris established...
Join us IN -PERSON for Clinical Cardiology & Critical Care on Friday, February 21, 2025! *EARLY BIRD REGISTRATION OPEN UNTIL SUNDAY, JANUARY 12, 2025* The inaugural Clinical Cardiology & Critical Care Update 2025 is proudly presented in partnership by the Ted Rogers Centre for Heart Research and the Peter Munk Cardiac Centre. This one-day conference will be held from 7:30 […]
Join us Thursday, October 17, 2024 for ECHO PITCH, a special event where four top cardiovascular health start-ups compete for funding from a $250,000 pool in front of a panel of judges and a live audience. These four finalists have been selected from the Entrepreneurship for Cardiovascular Health Opportunities (ECHO) program, where they received 12 months of hands-on entrepreneurship training and mentorship.
We’re bringing together a multi-disciplinary community of researchers, clinicians, and engineers, to share the latest discoveries, insights, and innovations in cardiovascular science, with a focus on heart failure. You can expect an exciting scientific program highlighting ground-breaking collaborative research, interactive workshops, and networking opportunities, including a fun social hour.
